Under a Mask of AI Doomerism, the Familiar Face of Eugenics
By Émile P. Torres,
Truthdig
| 10. 17. 2025
In a new book, Eliezer Yudkowsky and Nate Soares hide their radical transhumanist agenda under the cover of concern about “AI safety.”
The Internet philosopher Eliezer Yudkowsky has been predicting the end of the world for decades. In 1996, he confidently declared that the singularity — the moment at which computers become more “intelligent” than humanity — would happen in 2021, though he quickly updated this to 2025. He also predicted that nanotechnology would suddenly emerge and kill everyone by 2010. In the early aughts, the self-described “genius” claimed that his team of “researchers” at the Singularity Institute would build an artificial superintelligence “probably around 2008 or 2010,” at which point the world would undergo a fundamental and irreversible transformation.
Though none of those things have come to pass, that hasn’t deterred him from prophesying that the end remains imminent. Most recently, he’s been screaming that advanced AI could soon destroy humanity, and half-jokingly argued in 2022 that we should accept our fate and start contemplating how best to “die with dignity.”
Yudkowsky carries on his indefatigable doomsaying in a new book, co-written with his fellow apocalypticist Nate Soares, “If Anyone Builds It, Everyone Dies.” The conclusion is in...
Related Articles
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...
By Alex Aylward, Daniel J. Fairbanks, Maria Kiladi, and Gregory Radick , Heredity | 04.20.2026
Genetics and eugenics co-evolved at the beginning of the twentieth century and remained associated through the 1940s and beyond. Early geneticists were far from unanimous in their views on eugenics; some avidly supported the movement, whereas others openly opposed it...
By Sriparna Roy, Reuters | 04.23.2026
The U.S. Food and Drug Administration has approved Regeneron’s gene therapy for a rare genetic form of deafness, the company said on Thursday.
This approval, granted under the FDA’s new priority voucher program, marks the introduction of the first gene...
By Peter Ward, Slate | 03.30.2026
I’m in a cramped examination room at a clinic in Panama City. The lights are dim, and calming classical music plays from built-in speakers. A nurse has injected a dose of stem cells into Kenneth Scott through an IV in...